Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Announces First Patient Dosed in Phase 1 Trial of AlloNK® Cell Therapy Candidate in Lupus Nephritis
Read Article
News
2024
2023
Archive
Search news articles
November 28, 2016
PHASERX RECEIVES ORPHAN DRUG DESIGNATION FROM FDA FOR PRX-OTC FOR THE TREATMENT OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY
November 10, 2016
CIDARA PROVIDES CORPORATE UPDATE AND REPORTS THIRD QUARTER 2016 FINANCIAL RESULTS
November 10, 2016
VIVEVE ANNOUNCES NEW BRAND IDENTITY GENEVEVE™ BY VIVEVE
November 10, 2016
VIVEVE® REPORTS RECORD THIRD QUARTER FINANCIAL RESULTS
November 10, 2016
AUDENTES THERAPEUTICS REPORTS THIRD QUARTER 2016 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
November 8, 2016
PHASERX ANNOUNCES POSITIVE SAFETY RESULTS FROM LARGE ANIMAL STUDY WITH HYBRID MRNA DELIVERY TECHNOLOGY
November 7, 2016
PHASERX REPORTS THIRD QUARTER 2016 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
November 7, 2016
ACHAOGEN REPORTS THIRD QUARTER 2016 FINANCIAL RESULTS AND ANNOUNCES ACCELERATION OF EXPECTED TIMELINE FOR REPORTING TOP-LINE RESULTS FROM PLAZOMICIN PROGRAM
November 4, 2016
PULMATRIX REPORTS THIRD QUARTER 2016 FINANCIAL RESULTS AND BUSINESS UPDATE
November 2, 2016
CIDARA THERAPEUTICS AND SQUARE 1 BANK ANNOUNCE $20 MILLION CREDIT FACILITY
« Previous Page
1
…
89
90
91
92
93
…
118
Next Page »